Researchers discovered that those who received the injections experienced a 50% reduced rate of alcohol intoxication than those who did not receive a prescription.
They also discovered that off-label use of the medications may benefit opioid addicts.
Researchers examined glucagon-like peptide-1 receptor agonists (GLP-1 RA), which they claimed contained the medication Ozempic, and/or glucose-dependent insulinotropic polypeptide (GIP) medications, which they claimed included the brand name Mounjaro, in a study that was published in the journal Addiction.
Because these medications not only increase appetite but also alter brain regions that sustain addictive behavior, they may help prevent addictions.
Of the 817,309 individuals with a history of alcohol use problem that the researchers examined, 5,621 were prescribed a GLP-1 RA or GIP.
They discovered that the rate of alcohol intoxication was 50% lower for those with alcohol use disorder who were on GLP-1 RA or GIP than for those who were not.
